Shenzhen Mindray Bio-Medical Electronics Co., Ltd.

SZSE:300760 Stock Report

Market Cap: CN¥299.7b

Shenzhen Mindray Bio-Medical Electronics Management

Management criteria checks 2/4

We currently do not have sufficient information about the CEO.

Key information

Hao Wu

Chief executive officer

CN¥22.6m

Total compensation

CEO salary percentagen/a
CEO tenure8yrs
CEO ownershipn/a
Management average tenureno data
Board average tenure6.6yrs

Recent management updates

Recent updates

Does Shenzhen Mindray Bio-Medical Electronics (SZSE:300760) Have A Healthy Balance Sheet?

Dec 03
Does Shenzhen Mindray Bio-Medical Electronics (SZSE:300760) Have A Healthy Balance Sheet?

We Like Shenzhen Mindray Bio-Medical Electronics' (SZSE:300760) Returns And Here's How They're Trending

Nov 18
We Like Shenzhen Mindray Bio-Medical Electronics' (SZSE:300760) Returns And Here's How They're Trending

Is There An Opportunity With Shenzhen Mindray Bio-Medical Electronics Co., Ltd.'s (SZSE:300760) 27% Undervaluation?

Oct 24
Is There An Opportunity With Shenzhen Mindray Bio-Medical Electronics Co., Ltd.'s (SZSE:300760) 27% Undervaluation?

Shenzhen Mindray Bio-Medical Electronics (SZSE:300760) Ticks All The Boxes When It Comes To Earnings Growth

Oct 08
Shenzhen Mindray Bio-Medical Electronics (SZSE:300760) Ticks All The Boxes When It Comes To Earnings Growth

Risks To Shareholder Returns Are Elevated At These Prices For Shenzhen Mindray Bio-Medical Electronics Co., Ltd. (SZSE:300760)

Aug 12
Risks To Shareholder Returns Are Elevated At These Prices For Shenzhen Mindray Bio-Medical Electronics Co., Ltd. (SZSE:300760)

Shareholders Would Enjoy A Repeat Of Shenzhen Mindray Bio-Medical Electronics' (SZSE:300760) Recent Growth In Returns

Jul 28
Shareholders Would Enjoy A Repeat Of Shenzhen Mindray Bio-Medical Electronics' (SZSE:300760) Recent Growth In Returns

Estimating The Fair Value Of Shenzhen Mindray Bio-Medical Electronics Co., Ltd. (SZSE:300760)

Jun 06
Estimating The Fair Value Of Shenzhen Mindray Bio-Medical Electronics Co., Ltd. (SZSE:300760)

These 4 Measures Indicate That Shenzhen Mindray Bio-Medical Electronics (SZSE:300760) Is Using Debt Safely

May 21
These 4 Measures Indicate That Shenzhen Mindray Bio-Medical Electronics (SZSE:300760) Is Using Debt Safely

Analysts Have Made A Financial Statement On Shenzhen Mindray Bio-Medical Electronics Co., Ltd.'s (SZSE:300760) First-Quarter Report

Apr 30
Analysts Have Made A Financial Statement On Shenzhen Mindray Bio-Medical Electronics Co., Ltd.'s (SZSE:300760) First-Quarter Report

Shenzhen Mindray Bio-Medical Electronics Co., Ltd.'s (SZSE:300760) Share Price Not Quite Adding Up

Apr 21
Shenzhen Mindray Bio-Medical Electronics Co., Ltd.'s (SZSE:300760) Share Price Not Quite Adding Up

Shenzhen Mindray Bio-Medical Electronics (SZSE:300760) Looks To Prolong Its Impressive Returns

Apr 02
Shenzhen Mindray Bio-Medical Electronics (SZSE:300760) Looks To Prolong Its Impressive Returns

CEO

Hao Wu (52 yo)

8yrs

Tenure

CN¥22,623,200

Compensation

Mr. Hao Wu serves as Managing Director of Shenzhen Mindray Bio-Medical Electronics Co., Ltd and has been its Director since January 05, 2017 and was its Executive Deputy General Manager. Mr. Wu graduated f...


Board Members

NamePositionTenureCompensationOwnership
Hao Wu
MD & Director8yrsCN¥22.62mno data
Yanmei Guo
Executive Deputy GM & Director8yrsCN¥13.32mno data
Xiting Li
Chairman8yrsCN¥26.63m27.04%
CN¥ 81.1b
Hang Xu
Director & Chairman of Mindray Medical International Ltd34yrsno data24.55%
CN¥ 73.6b
Cheng Minghe
Vice Chairman of the Board8yrsCN¥5.04m4.26%
CN¥ 12.8b
Zhi Tang
Chairman of the Supervisory Board8yrsno datano data
Qiang Ji
Non-Employee Supervisor5.2yrsno datano data
Huming Liang
Independent Director3.7yrsCN¥400.00k0.00011%
CN¥ 329.7k
Shanrong Hu
Independent Director1.7yrsCN¥233.30kno data
Xianyi Zhou
Independent Director1.7yrsCN¥233.30kno data
Shengping Gao
Independent Director1.7yrsCN¥233.30kno data
Jing Xu
Independent Director1.7yrsCN¥233.30kno data

6.6yrs

Average Tenure

61.5yo

Average Age

Experienced Board: 300760's board of directors are considered experienced (6.6 years average tenure).


Company Analysis and Financial Data Status

DataLast Updated (UTC time)
Company Analysis2025/01/02 03:54
End of Day Share Price 2025/01/02 00:00
Earnings2024/09/30
Annual Earnings2023/12/31

Data Sources

The data used in our company analysis is from S&P Global Market Intelligence LLC. The following data is used in our analysis model to generate this report. Data is normalised which can introduce a delay from the source being available.

PackageDataTimeframeExample US Source *
Company Financials10 years
  • Income statement
  • Cash flow statement
  • Balance sheet
Analyst Consensus Estimates+3 years
  • Forecast financials
  • Analyst price targets
Market Prices30 years
  • Stock prices
  • Dividends, Splits and Actions
Ownership10 years
  • Top shareholders
  • Insider trading
Management10 years
  • Leadership team
  • Board of directors
Key Developments10 years
  • Company announcements

* example for US securities, for non-US equivalent regulatory forms and sources are used.

Unless specified all financial data is based on a yearly period but updated quarterly. This is known as Trailing Twelve Month (TTM) or Last Twelve Month (LTM) Data. Learn more here.

Analysis Model and Snowflake

Details of the analysis model used to generate this report is available on our Github page, we also have guides on how to use our reports and tutorials on Youtube.

Learn about the world class team who designed and built the Simply Wall St analysis model.

Industry and Sector Metrics

Our industry and section metrics are calculated every 6 hours by Simply Wall St, details of our process are available on .

Analyst Sources

Shenzhen Mindray Bio-Medical Electronics Co., Ltd. is covered by 52 analysts. 30 of those analysts submitted the estimates of revenue or earnings used as inputs to our report. Analysts submissions are updated throughout the day.

AnalystInstitution
Sandra SunBofA Global Research
Zhishun SiuCCB International Securities Limited
Yue GaoChangjiang Securities Co. LTD.